Blackhawk’s Asthmatic AI Progresses in Clinical Trials

Blackhawk Resource (TSE:BLR) has released an update.

Blackhawk Growth Corp. announces significant progress with its affiliate, Asthmatic AI, completing trials with 50 participants and advancing to tests with 250 more individuals for its pioneering asthma attack prediction technology. This innovative approach integrates wearable devices and smartphone apps to preemptively address asthma attacks by analyzing personal health data alongside environmental factors. Additionally, the Hardenbrook Group is consolidating its health-tech AI ventures, including Asthmatic AI, with plans for Life AI Corp to serve as a holding entity and future public listing.

For further insights into TSE:BLR stock, check out TipRanks’ Stock Analysis page.